Efficacy of Bortezomib followed by local irradiation in two patients with extramedullary plasmacytomas

Leukemia Research

Volumn 32, Issue 5, 2008, Pages 841-843

  Varettoni, M ^a   Mangiacavalli, S ^a   Zappasodi, P ^a   Pica, G M ^a   Lazzarino, M ^a   Corso, A ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; DEXAMETHASONE;

ADULT; AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; HISTOLOGY; HUMAN; LETTER; MALE; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMACYTOMA; PRIORITY JOURNAL;

EID: 40149089426     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.09.013     Document Type: Letter

References (12)

1. J. Bladé R.A. Kyle P.R. Greipp Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years Br J Haematol 93 1996 345 351
2. F.L. Ampil T.G. Borski C.A.O. Nathan Cavernous sinus involvement by extramedullary plasmacytoma of the sphenoid sinus. An argument for the use of adjuvant chemotherapy. Leuk Lymphoma 43 10 2002 2037 2040
3. F.R. Miller P. Lavertu J.R. Wanamaker Plasmacytomas of the head and neck Otolaryngol Head Neck Surg 199 1998 614 618
4. B. Patriarca S. Prosdocimo V. Tomadini Efficacy of Bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation Haematologica 90 2005 278 279
5. L. Rosiñol M.T. Cibeira C. Uriburu Bortezomib: an effective agent in extramedullary disease in multiple myeloma Eur J Hematol 2006 1 4
6. W. Tsang M.K. Gospodarowicz M. Pintilie Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome Int J Radiat Oncol Biol Phys 50 2001 113 120
7. T. Hideshima P.J. Richardson D. Chaucan The proteasome inhibitor PS-341 inhibits growth, induced apoptosis, and overcomes drug resistance in human multiple myeloma cells Cancer Res 61 7 2001 3071 3076
8. P.G. Richardson B. Barlogie J. Berenson A phase 2 study of Bortezomib in relapsed, refractory myeloma N Engl J Med 348 2003 2609 2617
9. S. Jagannath B. Barlogie J. Berenson A phase 2 study of two doses of Bortezomib in relapsed or refractory myeloma Br J Haematol 127 2004 165 172
10. P.G. Richardson P. Sonneveld M.W. Schuster Bortezomib or high-dose dexamethasone for relapsed multiple myeloma N Engl J Med 352 2005 2487 2498
11. P.G. Richardson H. Briemberg S. Jagannath Frequency, characteristics and reversibility of peripheral neuropathy during treatment of advanced myeloma with bortezomib J Clin Oncol 24 19 2006 3113 3118
12. L. Rosiñol M.T. Cibeira J. Bladé Extramedullary multiple myeloma escapes the effect of thalidomide Haematologica 89 2004 832 836